D T Fearon

3.8k total citations · 4 hit papers
29 papers, 3.2k citations indexed

About

D T Fearon is a scholar working on Immunology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, D T Fearon has authored 29 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 11 papers in Hematology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in D T Fearon's work include Complement system in diseases (15 papers), Blood groups and transfusion (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). D T Fearon is often cited by papers focused on Complement system in diseases (15 papers), Blood groups and transfusion (7 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). D T Fearon collaborates with scholars based in United States, United Kingdom and Canada. D T Fearon's co-authors include K. Frank Austen, Louise Collins, John M. Weiler, M. R. Daha, Joseph J. Burge, A Nicholson-Weller, P F Weller, K. Frank Austen, Thomas F. Tedder and Paul S. Changelian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

D T Fearon

29 papers receiving 2.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte

1980 539 citations D T Fearon The Journal of Experimental Medicine profile →
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

1982 495 citations A Nicholson-Weller, Joseph J. Burge et al. The Journal of Immunology profile →
Control of the amplification convertase of complement by the plasma protein beta1H.

1976 474 citations John M. Weiler, K. Frank Austen et al. profile →
Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures.

1983 407 citations D T Fearon, Louise Collins The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D T Fearon United States	18	2.2k	898	588	578	419	29	3.2k
P J Lachmann United Kingdom	29	1.8k 0.8×	840 0.9×	543 0.9×	435 0.8×	301 0.7×	76	2.9k
Rudolf A. Manz Germany	36	3.7k 1.7×	791 0.9×	1.1k 1.9×	790 1.4×	306 0.7×	77	6.0k
J Brochier France	34	1.4k 0.7×	1.1k 1.2×	1.1k 1.9×	740 1.3×	155 0.4×	135	3.8k
Enrique Rabellino United States	22	1.8k 0.8×	800 0.9×	582 1.0×	664 1.1×	237 0.6×	29	3.1k
Anders G. Sjöholm Sweden	30	1.8k 0.8×	666 0.7×	415 0.7×	263 0.5×	173 0.4×	90	3.1k
P J Capel Netherlands	34	2.6k 1.2×	556 0.6×	1.8k 3.1×	2.3k 4.0×	296 0.7×	74	5.0k
Hiromi Kubagawa United States	40	4.2k 2.0×	736 0.8×	1.4k 2.3×	1.5k 2.6×	212 0.5×	102	5.8k
Flavius Martin United States	27	4.8k 2.2×	362 0.4×	1.1k 1.9×	1.1k 1.9×	228 0.5×	39	6.5k
Soo Young Yang United States	31	4.4k 2.0×	748 0.8×	877 1.5×	384 0.7×	238 0.6×	90	5.4k
Viktor A. Bokisch United States	18	1.2k 0.5×	405 0.5×	474 0.8×	469 0.8×	160 0.4×	23	2.1k

Countries citing papers authored by D T Fearon

Since Specialization

Citations

This map shows the geographic impact of D T Fearon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D T Fearon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D T Fearon more than expected).

Fields of papers citing papers by D T Fearon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D T Fearon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D T Fearon. The network helps show where D T Fearon may publish in the future.

Co-authorship network of co-authors of D T Fearon

This figure shows the co-authorship network connecting the top 25 collaborators of D T Fearon. A scholar is included among the top collaborators of D T Fearon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D T Fearon. D T Fearon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hammel, James M., Nozomu Kobayashi, Mutsumi Ito, et al.. (1999). Transplanted hepatocytes infected with a complement receptor type 1 (CR1)-containing recombinant adenovirus are resistant to hyperacute rejection. Transplantation Proceedings. 31(1-2). 939–939. 4 indexed citations

Nakamura, Junko, et al.. (1997). Construction, function and in vivo expression of a complement receptor type 1 containing recombinant adenovirus for use in xenotransplantation. Transplantation Proceedings. 29(1-2). 933–934. 1 indexed citations

Fearon, D T. (1995). The B lymphocyte as an immunotherapeutic target. QJM. 88(3). 149–53. 2 indexed citations

Fearon, D T, et al.. (1993). Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts.. PubMed. 25(1 Pt 1). 410–1. 9 indexed citations

Krieger, Jeffrey, et al.. (1993). Human Anti-Endotoxin Antibody HA-1A Mediates Complement-Dependent Binding of Escherichia coli J5 Lipopolysaccharide to Complement Receptor Type 1 of Human Erythrocytes and Neutrophils. The Journal of Infectious Diseases. 167(4). 865–875. 21 indexed citations

Xia, Wei, et al.. (1992). Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1.. PubMed. 24(2). 479–80. 17 indexed citations

Tedder, Thomas F., et al.. (1990). Is abortive entry of b cells into cycle a negative signal for immunoglobulin synthesis. The FASEB Journal. 4(7). 1723. 2 indexed citations

Changelian, Paul S. & D T Fearon. (1986). Tissue-specific phosphorylation of complement receptors CR1 and CR2.. The Journal of Experimental Medicine. 163(1). 101–115. 93 indexed citations

Changelian, Paul S., R M Jack, Louise Collins, & D T Fearon. (1985). PMA induces the ligand-independent internalization of CR1 on human neutrophils.. The Journal of Immunology. 134(3). 1851–1858. 85 indexed citations

10.

Moore, Francis D., K. Frank Austen, & D T Fearon. (1982). Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.. The Journal of Immunology. 128(3). 1302–1306. 29 indexed citations

11.

Tedder, Thomas F., D T Fearon, G. Larry Gartland, & M D Cooper. (1982). Expression of complement receptor type one (for C3b) on human natural killer cells, B cells and lymphoblastoid cell lines. Molecular Immunology. 19(11). 1405–1405. 3 indexed citations

12.

Nicholson-Weller, A, Joseph J. Burge, D T Fearon, P F Weller, & K. Frank Austen. (1982). Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.. The Journal of Immunology. 129(1). 184–189. 495 indexed citations breakdown →

13.

Fearon, D T, et al.. (1981). Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes.. The Journal of Experimental Medicine. 153(6). 1615–1628. 95 indexed citations

14.

Fearon, D T. (1980). Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. The Journal of Experimental Medicine. 152(1). 20–30. 539 indexed citations breakdown →

15.

Kaneko, Isamu, D T Fearon, & K. Frank Austen. (1980). Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.. The Journal of Immunology. 124(3). 1194–1198. 61 indexed citations

16.

Kazatchkine, M, U Nydegger, & D T Fearon. (1979). La voie alterne du complément.. La Nouvelle presse médicale. 8(26). 2 indexed citations

17.

Kazatchkine, M, D T Fearon, J E Silbert, & K. Frank Austen. (1979). Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.. The Journal of Experimental Medicine. 150(5). 1202–1215. 144 indexed citations

18.

Weiler, John M., Roger W. Yurt, D T Fearon, & K. Frank Austen. (1978). Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin.. The Journal of Experimental Medicine. 147(2). 409–421. 135 indexed citations

19.

Fearon, D T & K. Frank Austen. (1977). Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins. The Journal of Experimental Medicine. 146(1). 22–33. 145 indexed citations

20.

Ruddy, Shaun, D T Fearon, & K. Frank Austen. (1973). Participation of Factors B, D, E, and C3b Inactivator in Cobra Venom (CVF)-Induced Activation of the Alternate C Pathway. The Journal of Immunology. 111(1). 289–290. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact